Frequently Asked Questions

The Innotech Business Intelligence Report is a quarterly commercial intelligence briefing for senior leaders in medical devices. It covers a named therapy area and geography: competitive landscape, regulatory and reimbursement developments, procurement activity, M&A and investment signals, talent moves, and earnings data, and closes with Action Intelligence: three specific priorities for the next 90 days, each grounded in what the research found.

Every claim is sourced. Every figure is named. There are no estimates presented as facts and no generic market commentary. The report is built specifically for commercial leaders who need to act on intelligence, not just read it.

Every retained search Innotech runs starts with a detailed read of the market: who is hiring, who has just been funded, which companies are pivoting their commercial strategy, and which are quietly building a team ahead of a product launch. That intelligence is gathered systematically, therapy area by therapy area, as a direct byproduct of operating at director and board level across the UK, US, and Republic of Ireland.

By the time a company instructs a retained search for a VP Sales or a Market Access Director, something has already changed in their commercial position. Innotech sees those signals early, because the companies experiencing them are the ones making hiring decisions. The BI Report makes that intelligence available to the people who can act on it.

Founders, CEOs, Managing Directors, VP Sales, VP Marketing, Market Access Directors, and Commercial Directors operating in medical devices across the UK, US, and Republic of Ireland. The report is written for someone who already knows the market and needs to know what is moving in it right now, not a primer on the therapy area.

If you are pre-commercial or exploring a therapy area for the first time, the Standard Grade report will be useful context but the Reference Grade may be the better starting point for your situation.

Current Standard Grade reports are available in cardiovascular imaging AI, IV therapy, and orthopaedics. Geographies covered are United States, United Kingdom, and Republic of Ireland, individually or in combination.

If your therapy area or geography is not listed, a Reference Grade bespoke commission can be produced for any medical device commercial leadership market. Contact Blair Anderson to discuss scope.

Fifteen sections per report: market snapshot, major announcements and product advancements, business wins and procurement activity, M&A and investment activity, UK funding and investment tracker, competitive landscape, horizon intelligence, regulatory and compliance updates, reimbursement and payer intelligence, expert opinions and KOL intelligence, digital and social listening, global events calendar, talent and commercial intelligence, earnings and financial signals, and Action Intelligence.

Every report also includes a “What Is Not In This Report and Why” section: a transparent statement of what the research could not verify and what the Reference Grade provides instead.

Action Intelligence is the final section of every report. It translates everything the research found into three specific commercial priorities for the next 90 days, each classified RED (act now), AMBER (monitor closely), or GREEN (track, no immediate action required).

Each priority states the action, the intelligence basis for it, citing the specific findings from the report, and the consequence of not acting. In your subscribed report, these priorities are written around your company’s specific commercial position, not the category in general.

Three things distinguish it. First, every claim is sourced: named organisation, named document, named date. No unattributed statistics, no estimated figures presented as fact. Second, it is written for a specific commercial audience making specific decisions, not for a general readership. Third, it closes with Action Intelligence: a specific 90-day agenda, not a summary of what was covered.

Generic market research describes the market. This report tells you what to do about it on Monday.

Yes. Sample reports are available on the BI page for cardiovascular imaging AI, IV therapy, and orthopaedics. These are full Standard Grade reports: the only difference from a subscribed report is that the Action Intelligence section is written for the category generally, not for your specific commercial position.

If you want to see what a report built around your situation would look like before committing to a subscription, email Blair Anderson to discuss a bespoke sample or trial commission.

• Standard (single report): £950 / $1,190 / €1,100
• Annual Standard (four reports): £2,750 / $3,450 / €3,200
• Reference Grade (single bespoke commission): £3,500 / $4,400 / €4,100

VAT is added at the applicable rate for UK subscribers. US and ROI subscribers are not subject to UK VAT. Currency is determined automatically by your location at checkout.

A single report is a one-off purchase: you receive one quarterly report and there is no ongoing commitment. An annual subscription delivers four reports over twelve months at a saving of £1,050 versus four single purchases.

The more significant difference is personalisation. From the second report onwards, your annual subscription includes a subscriber questionnaire. Your responses become the commissioning brief for the next report, shaping what gets researched and how the Action Intelligence priorities are framed around your commercial situation. Single report purchases do not include this personalisation layer.

Yes, for most subscribers. The value of commercial intelligence compounds across quarters: the second report is more useful than the first because it is built on what you told us after reading the first. The third is more useful still. A single report gives you a snapshot. Four reports give you a moving picture of your market across a year.

If you are uncertain, start with a single report. If the Action Intelligence priorities are relevant to your situation, the annual subscription is the natural next step.

Yes. Bank transfer is available for annual subscriptions or where card payment is not possible for procurement reasons. Email blair.anderson@innotechrecruit.com and a proforma invoice and bank details will be provided.

Reports are delivered in the first week of each quarter: by the end of the first Friday of January, April, July, and October. Your delivery date is confirmed in your order confirmation. If a report is delayed beyond the first week, Blair Anderson will contact you by email before the due date.

By email as a PDF attachment, sent directly from blair.anderson@innotechrecruit.com to the address registered on your subscription. The report is named to you and marked confidential on the cover page. It is not shared with any other subscriber. Check your spam folder if it hasn’t arrived: some corporate email systems filter PDF attachments from outside your domain.

Standard subscriptions are single-user licences: the report is for your use only. Short extracts may be cited in internal presentations with clear attribution to Innotech Recruit. Sharing the full report externally or with third parties outside your organisation is not permitted under a Standard licence.

If you want to extend access to your wider team, email Blair Anderson to discuss a site or corporate licence.

After your first report is delivered, you will receive a short questionnaire by email. It covers which sections were most useful, what commercial decisions you are currently working on, and whether there are specific angles you would like the next report to go deeper on. Responses are read directly by Blair Anderson and used to commission the research for your next report.

Completing it is voluntary, but subscribers who respond get a meaningfully more relevant second report. Non-response does not affect delivery.

Yes. Email blair.anderson@innotechrecruit.com at least 30 days before your next delivery date with the change you would like. Changes received after that point take effect on the following quarter, as the research phase begins 4–5 weeks before delivery.

Use the subscriber questionnaire to flag which sections matter most. Your responses are read by Blair Anderson and used to weight the next report accordingly: more depth on competitive intelligence, for example, or heavier emphasis on reimbursement and payer analysis.

For substantially deeper coverage of a specific area, or for named buyer contact intelligence, a Reference Grade commission is the right route.

Standard Grade is built entirely from publicly available, named, and verifiable sources. That discipline is the foundation of every report. Reference Grade goes further. It includes intelligence that public sources cannot provide:

• Named buyer contacts at health-system or NHS trust level
• KOL mapping with verified committee memberships and commercial affiliations
• Employee sentiment intelligence from named platforms
• A bespoke commissioning brief built around your specific commercial situation: your therapy area, your competitive position, your specific question
• Client-specific strategic framing in the Action Intelligence section

Reference Grade reports are commissioned for a specific company and a specific commercial situation. They are not a subscription product: each one is a standalone commission.

Reference Grade is the right choice when you are preparing a specific commercial action that depends on intelligence beyond what public sources provide. Common contexts include: preparing a tender submission and needing named trust-level procurement contacts; entering a new market and needing to know who the real decision-makers are; responding to a competitive threat and needing to understand the competitor’s commercial infrastructure; or making a senior hiring decision that depends on knowing the available talent landscape in a specific geography and therapy area.

Email Blair Anderson directly at blair.anderson@innotechrecruit.com or call +44 779 367 1203. The conversation starts with your commercial situation: what decision you are trying to make and what intelligence would change or confirm it. Scope and pricing are agreed before any research begins. Reference Grade commissions are priced from £3,500 / $4,400 / €4,100.

Each report is produced using Innotech SIGNAL Intelligence: a structured research methodology that draws on regulatory databases, company filings, NHS procurement frameworks, payer policy documents, peer-reviewed publications, earnings transcripts, and named trade press. Research is conducted across a 90-day window and synthesised into the report structure.

All sources are listed by name and date at the end of every report. Where a source could not be independently verified, the claim is excluded and the absence is stated explicitly. Company-stated figures are flagged as such and not presented as independently verified data.

Every claim in the report is traceable to a named source. If you believe a specific claim is inaccurate, email Blair Anderson with the section, the claim, and the evidence that contradicts it. Where an error is confirmed, a correction note is issued to all subscribers who received that report.

AI research tools are used in the production pipeline: specifically Perplexity AI (primary research), Grok (secondary research pass on regulatory and personnel sections), and Claude AI (synthesis and structuring). Each tool operates under a strict source discipline protocol: claims without a named, verifiable primary or secondary source are excluded, not estimated. Company-stated figures are flagged explicitly.

The fabrication audit and final editorial review are conducted by Blair Anderson before every report ships. No AI-generated content that has not been verified against a named source appears in a published report.

Your name, job title, company, work email address, geography and therapy area preferences, questionnaire responses, and payment confirmation records. Full detail, including retention periods and third-party processors, is in the BI Subscriber Privacy Notice at privacy.innotechrecruit.com/bi.

Your data is never sold. It is not shared with competitors in your therapy area. It is processed by a small number of named third-party platforms: Stripe (payment), HubSpot (subscription management), and the AI research tools used in production, all under data processing agreements. Full detail is in the BI Subscriber Privacy Notice at privacy.innotechrecruit.com/bi.

Email blair.anderson@innotechrecruit.com at least 30 days before your next renewal date. No reason is required. Blair will confirm cancellation in writing and ensure no further charges are made. Full cancellation terms are in the BI Subscription Terms at terms.innotechrecruit.com/bi.

• Subscription Terms: terms.innotechrecruit.com/bi (UK, USA, and ROI versions available via the jurisdiction tab)
• Privacy Notice: privacy.innotechrecruit.com/bi (covers UK GDPR, EU GDPR, and CCPA/CPRA)
• Subscriber Support: support.innotechrecruit.com/bi